fraxetin and Pancreatic-Neoplasms

fraxetin has been researched along with Pancreatic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for fraxetin and Pancreatic-Neoplasms

Article	Year
The anti-dysenteric drug fraxetin enhances anti-tumor efficacy of gemcitabine and suppresses pancreatic cancer development by antagonizing STAT3 activation. Aging, 2021, 07-28, Volume: 13, Issue:14 Fraxetin, a natural product isolated and purified from the bark of Topics: Animals; Apoptosis; Cell Line, Tumor; Coumarins; Deoxycytidine; Epithelial-Mesenchymal Transition; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Reactive Oxygen Species; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays	2021

Article

Year

The anti-dysenteric drug fraxetin enhances anti-tumor efficacy of gemcitabine and suppresses pancreatic cancer development by antagonizing STAT3 activation.

Aging, 2021, 07-28, Volume: 13, Issue:14

Fraxetin, a natural product isolated and purified from the bark of

Topics: Animals; Apoptosis; Cell Line, Tumor; Coumarins; Deoxycytidine; Epithelial-Mesenchymal Transition; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Reactive Oxygen Species; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays

2021